輸入代號或公司名稱後按 Enter
6662

樂斯科

-0.20 (-0.70%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
28.502成交張數17.81本益比1.71股價淨值比5.44%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025263年增 -10.2%
毛利率202539.9%最新一期
營業利益率202518.3%最新一期
每股盈餘20251.66年增 -3.5%
會計項目走勢2019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計63.7%56.4%53.8%55.7%60.6%60.8%60.1%
營業毛利(毛損)36.3%43.6%46.2%44.3%39.4%39.2%39.9%
營業毛利(毛損)淨額36.3%43.6%46.2%44.3%39.4%39.2%39.9%
推銷費用6.3%6.8%8.5%7.6%7.7%6.2%6.7%
管理費用9.6%10.8%13.9%15.8%12.5%14.0%14.9%
預期信用減損損失(利益)-0.1%-0.0%0.0%0.0%0.0%-0.0%0.0%
營業費用合計15.9%17.6%22.5%23.4%20.2%20.2%21.6%
營業利益(損失)20.4%26.0%23.7%20.9%19.2%19.1%18.3%
利息收入0.2%0.2%0.3%0.7%0.6%0.6%
其他收入0.4%0.0%0.0%0.0%0.6%0.3%0.4%
其他利益及損失淨額-0.1%0.1%0.1%-0.2%0.1%-1.2%0.1%
財務成本淨額0.1%0.3%0.4%0.5%0.5%0.6%0.8%
採用權益法認列之關聯企業及合資損益之份額淨額-0.9%0.2%1.2%2.0%3.3%0.6%0.3%
營業外收入及支出合計-0.6%0.3%1.1%1.6%4.2%-0.3%0.6%
稅前淨利(淨損)19.8%26.3%24.8%22.5%23.4%18.8%18.9%
所得稅費用(利益)合計4.0%5.3%5.0%4.6%4.6%3.7%2.7%
繼續營業單位本期淨利(淨損)15.9%21.0%19.8%17.9%18.8%15.1%16.2%
本期淨利(淨損)15.9%21.0%19.8%17.9%18.8%15.1%16.2%
確定福利計畫之再衡量數-0.0%-0.1%0.5%0.2%0.0%0.1%0.2%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益3.3%-4.1%-0.5%-3.1%-1.7%-5.1%2.6%
與不重分類之項目相關之所得稅-0.0%-0.0%0.1%0.1%0.0%0.0%0.0%
不重分類至損益之項目:3.3%-4.1%-0.2%-2.9%-1.7%-5.0%2.7%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.2%-0.6%-0.5%-0.1%-0.1%0.5%-1.3%
與可能重分類之項目相關之所得稅-0.0%-0.1%-0.1%-0.0%-0.0%0.1%-0.3%
後續可能重分類至損益之項目:-0.1%-0.5%-0.4%-0.0%-0.1%0.4%-1.1%
其他綜合損益(淨額)3.2%-4.5%-0.6%-3.0%-1.8%-4.6%1.6%
本期綜合損益總額19.0%16.5%19.2%14.9%17.0%10.4%17.8%
基本每股盈餘0.6%0.8%0.8%0.7%0.7%0.6%0.6%
稀釋每股盈餘0.6%0.8%0.8%0.7%0.7%0.6%0.6%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。